Hibernation resumes on this and nothing of much interest seems to be on the horizon. “Disappointing” sums this up.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025